← Back to Clinical Trials
Recruiting NCT07022067

EVOLVING AZIMUTH IN MUSA CONTEXT

Trial Parameters

Condition Heart Failure
Sponsor Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Study Type INTERVENTIONAL
Phase N/A
Enrollment 184
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-10-02
Completion 2025-06-30
Interventions
Telemonitoring app

Brief Summary

Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure

Eligibility Criteria

Inclusion Criteria: * Have been diagnosed with chronic CS according to the ESC guidelines; * Over 18 years of age; * Patients admitted to hospital or with access to first aid within the last year; * Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application); * Wi-Fi or 3G coverage at home; * Ability to give written informed consent. Exclusion Criteria: * Severe psychiatric disorder * Inability to use portable technologies * Patients unable to use the equipment provided * Patients who deny consent to study participation

Related Trials